DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo

11.42 0.21 (1.87%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BCRX $11.42 1.87%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $11.10
Previous Close $11.21
Daily Range $11.03 - $11.43
52-Week Range $7.85 - $16.83
Market Cap $836.4M
P/E Ratio -26.69
Dividend (Yield) $0.00 (0.0%)
Volume 424,931
Average Daily Volume 968,774
Current FY EPS -$0.60

Sector

Healthcare

Industry

Drug Makers

BioCryst Pharmaceuticals, Inc. (BCRX) Description

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections. Website: http://www.biocryst.com/

News & Commentary Rss Feed

We Believe Healthcare's Next Biotech Buyout Target Is…

Which biotech company will be the next buyout target? To answer this question, we turned to three of our healthcare contributors, and this is what they had to say.

Market Has Not Yet Noticed Potential in BioCryst Pharmaceuticals (BCRX); Have You?

New Strong Buy Stocks for August 11th

Esperion Therapeutics (ESPR) Looks Good: Stock Up 16.3%

Premarket Biotech Digest: SeekingAlpha Biotech Idea, Gilead Sales Updates, Sanofi Diabetes Collabora

Premarket Biotech Digest: SeekingAlpha Biotech Idea, Gilead Sales Updates, Sanofi Diabetes Collaboration

2 Biotech Stocks That Could Skyrocket In The Next 12 Months

3 Stocks Pushing The Health Care Sector Lower

Why BioCryst Pharmaceuticals Was Sent to the Guillotine

BioCryst Pharmaceuticals crushes Wall Street's second-quarter expectations, but gets hammered anyway. Find out why.

BioCryst Pharmaceuticals' (BCRX) CEO Jon Stonehouse on Q2 2015 Results - Earnings Call Transcript

Friday's ETF Movers: GDX, XBI

See More BCRX News...

BCRX's Top Competitors

BCRX $11.42 (1.87%)
Current stock: BCRX
AMGN $155.89 (0.11%)
Current stock: AMGN
GILD $107.78 (-0.19%)
Current stock: GILD
BIIB $303.69 (-0.26%)
Current stock: BIIB